Moderate to severe HIV-associated neurocognitive impairment

Eric Decloedt; Carla Freeman; Fleur M. Howells; Martine Casson-Crook; Maia Lesosky; Eleni Koutsilieri; Simon Lovestone; Gary Maartens; John A. Joska

doi:10.1097/md.0000000000005401

JOURNAL ARTICLE

Moderate to severe HIV-associated neurocognitive impairment

Eric Decloedt Carla Freeman Fleur M. Howells Martine Casson-Crook Maia Lesosky Eleni Koutsilieri Simon Lovestone Gary Maartens John A. Joska

Year: 2016 Journal: Medicine Vol: 95 (46)Pages: e5401-e5401 Publisher: Wolters Kluwer

DOI: 10.1097/md.0000000000005401

Get Full-Text PDF Get Analytical Report

Abstract

Adjunctive lithium pharmacotherapy in patients on ART with HAND was well tolerated but had no additional benefit on neurocognitive impairment.

Keywords:

Medicine Placebo Clinical endpoint Lithium (medication) Neurocognitive Internal medicine Randomized controlled trial Placebo-controlled study Psychiatry Double blind Cognition

Metrics

Cited By

1.44

FWCI (Field Weighted Citation Impact)

Refs

0.87

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

HIV Research and Treatment

Life Sciences → Immunology and Microbiology → Virology

HIV/AIDS Research and Interventions

Health Sciences → Medicine → Infectious Diseases

HIV/AIDS drug development and treatment

Health Sciences → Medicine → Infectious Diseases

Moderate to severe HIV-associated neurocognitive impairment

Abstract

Metrics

Citation History

Topics

Related Documents

Screening for HIV-Associated Neurocognitive Impairment

Lithium improves HIV-associated neurocognitive impairment

Real-World Impact of HIV-Associated Neurocognitive Impairment

HIV and Neurocognitive Impairment

Mental impairment and neurocognitive symptoms associated with HIV infection